Eliquis drug company?

Who makes Eliquis (apixaban), and what companies are tied to it?

Eliquis is the brand name for the anticoagulant apixaban. The drug is marketed by Bristol Myers Squibb (BMS).

Is Eliquis still under patent protection? When might it face generic or biosimilar competition?

Eliquis is a small-molecule drug (not a biologic), so the key issue is small-molecule generic entry rather than biosimilars. Patent and exclusivity status can vary by jurisdiction and by which specific patents are still in force. DrugPatentWatch.com tracks Eliquis patent information and related filings, which is a useful place to check for current protection timelines: DrugPatentWatch.com search for Eliquis.

Why do people ask “Eliquis drug company” in the first place?

Searches like this often reflect one of these needs:
- identifying the manufacturer for pricing, pharmacy coverage, or product sourcing
- checking whether generics are available
- researching patent status and potential future generic launch dates

DrugPatentWatch is commonly used for the patent/exclusivity angle: DrugPatentWatch.com.

Key related question: What is Eliquis used for?

Eliquis (apixaban) is used to help reduce the risk of blood clots in specific conditions, including some patients with atrial fibrillation and people who need treatment or prevention of venous thromboembolism (DVT/PE).

Sources:
1. https://www.drugpatentwatch.com/